• Nenhum resultado encontrado

[PDF] Top 20 Biologic therapy of rheumatoid arthritis

Has 10000 "Biologic therapy of rheumatoid arthritis" found on our website. Below are the top 20 most common "Biologic therapy of rheumatoid arthritis".

Biologic therapy of rheumatoid arthritis

Biologic therapy of rheumatoid arthritis

... Rheumatoid arthritis (RA) and juvenile idiopathic/rheuma- toid arthritis (JIA) are chronic, inflammatory, systemic, auto- immune diseases characterized by chronic arthritis leading to ... See full document

6

An Update of Glucocorticoid Therapy in Rheumatoid Arthritis: Do Benefits Outweigh the Risks?

An Update of Glucocorticoid Therapy in Rheumatoid Arthritis: Do Benefits Outweigh the Risks?

... early rheumatoid ar- thritis (duration less than 2 years) were randomly allocated to ...70% of the patients. The statistical analysis of ra- diographic scores was restricted to 106 patients for whom ... See full document

8

Bronchocentric granulomatosis in rheumatoid arthritis: case report and literature review

Bronchocentric granulomatosis in rheumatoid arthritis: case report and literature review

... history of RA treated with leflunomide and low dose methylprednisolone (4 mg/day), presented with low-grade fever, non-productive cough, excessive sweating, fatigue and malaise during the last two months, with no ... See full document

6

Study of advanced rheumatoid arthritis

Study of advanced rheumatoid arthritis

... drug therapy (9 ± ...system of rheumatic ...values of sensitivity/ speciicity ...sensitivity of the test ranges between 60% (early RA) and 77% (established ...titers of ACPA may occur ... See full document

10

A systems approach to rheumatoid arthritis.

A systems approach to rheumatoid arthritis.

... sets of molecular candidates. The first set of 15 known candidates were identified as the ones (Table 2); 1) that are currently being used as therapeutic targets in RA treatments or whose efficacy has been ... See full document

11

Research Article Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis

Research Article Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis

... compared to patients before TNFi exposure. RANK/RANKL signaling cross-talks with TNF signaling, as RANK is a TNF- superfamily member [56]. Upon activation, both RANK and TNF activate cytoplasmic kinases and adaptor ... See full document

10

Physiotherapy in rheumatoid arthritis: development of a practice guideline

Physiotherapy in rheumatoid arthritis: development of a practice guideline

... exercise therapy, there was overall con- sensus within the Guideline Steering Committee that exercise therapy should be aimed at patient- -specific limitations in activities or participation restrictions ... See full document

13

Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis.

Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis.

... aim of this study was to assess the change of IL-37 concentrations in rheumatoid arthritis (RA) patients under Disease- modifying anti-rheumatic drug (DMARD) therapy, and to establish a ... See full document

7

Extra-Articular Manifestations of Rheumatoid Arthritis, Now

Extra-Articular Manifestations of Rheumatoid Arthritis, Now

... Rheumatoid arthritis (RA) is a chronic systemic inlammatory disease, characterised by polyarthritis and extra-articular organ disease, including rheumatoid nodules, ophthalmologic manifestations, ... See full document

10

Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy?

Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy?

... combination of infliximab (3mg/kg iv every six weeks), methotrexate (15 mg/week) and predni so lone (10 mg once daily) being in remission in the last ...history of monoclonal gammopathy of un- ... See full document

5

A Rare Association of Rheumatoid Arthritis with Crohn’s Disease

A Rare Association of Rheumatoid Arthritis with Crohn’s Disease

... diagnosis of seropositive RA for 5 years, presented with the complaints of bloody diarrhea and abdominal ...combination of methotrexate, sülfasalazine and hydroxychloroquine, and the patient reported ... See full document

2

A role for angiogenesis in rheumatoid arthritis

A role for angiogenesis in rheumatoid arthritis

... control of angiogenic responses may be possible by coordinately inhibiting complementary potentiating events involved in ...case of RA, the ongoing inflammatory component presents an obvious and important ... See full document

9

Rev. Bras. Reumatol.  vol.52 número4 en v52n4a02

Rev. Bras. Reumatol. vol.52 número4 en v52n4a02

... recommendations of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology (SBR) to manage comorbidities in rheumatoid arthritis ...opinions of ... See full document

14

Real-World Outcomes of Biologic Therapy for Juvenile Idiopathic Arthritis Associated Uveitis

Real-World Outcomes of Biologic Therapy for Juvenile Idiopathic Arthritis Associated Uveitis

... Biologic therapy is a novel treatment modality with the aim of regulate the inflammatory process and has been successfully used in the treatment of several immune- mediated rheumatic ... See full document

5

Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt)

Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt)

... percentage of patients achieving functional re- mission through week 52 (HAQ ...difference of the individual com- ponents of DAS28-ESR swollen joint counts (SJC), tender joint counts (TJC), PGDA and ... See full document

9

Apoptosis as a Target for Gene Therapy in Rheumatoid Arthritis

Apoptosis as a Target for Gene Therapy in Rheumatoid Arthritis

... treatment of arthritis will require the elimination of proliferating synoviocytes and arthritogenic lymphocytes that initiate and perpetu- ate joint ...in rheumatoid synovium or acti- vated ... See full document

9

Predictors and causes of first-line biologic agent discontinuation in rheumatoid arthritis: data from Reuma.pt

Predictors and causes of first-line biologic agent discontinuation in rheumatoid arthritis: data from Reuma.pt

... association of several sociodemographic and clinical characteristics and bDMARDs discontinua - tion, in a ‘real world’ setting which easily translates to clinical ...beginning of TNFi bDMARD use in Portugal ... See full document

8

Determinants of non-nociceptive pain in Rheumatoid Arthritis

Determinants of non-nociceptive pain in Rheumatoid Arthritis

... determInAnts of neuropAthIc pAIn In crude regression analysis, female sex was predictive of LANSS and PDQ NP and disease duration was in- versely associated with LANSS NP (Table ...predictors of NP ... See full document

13

A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.

A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.

... This is interesting, as the RA patients demonstrated significantly lower global assessment, pain, spine pain, spine pain at night, joint pain and fatigue than the PsA and the ax-SpA pa- tients, values adjusted for age ... See full document

11

Rev. Bras. Reumatol.  vol.54 número6

Rev. Bras. Reumatol. vol.54 número6

... with contrast-enhanced MRI and US in the treatment response evaluation. Sixteen patients with active RA underwent whole- body PET, contrast-enhanced MRI and US of one knee (i.e., the joint referred to by patients ... See full document

9

Show all 10000 documents...